Case Report: Roxadustat in Combination With Rituximab Was Used to Treat EPO-Induced Pure Red Cell Aplasia

Recombinant human erythropoietin (rHuEPO) is a drug given to patients who have low hemoglobin related to chronic kidney disease or other anemia-related diseases. Some patients who receive rHuEPO repeatedly develop anti-rHuEPO-neutralizing antibodies, leading to the occurrence of pure red cell aplasi...

Descripción completa

Detalles Bibliográficos
Autores principales: You, Xiaoe, Guo, Baochun, Wang, Zhen, Ma, Hualin, Zhou, Ru, Liu, Lixia, Zhang, Xinzhou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Nephrology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10479623/
https://www.ncbi.nlm.nih.gov/pubmed/37675011
http://dx.doi.org/10.3389/fneph.2022.847847

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10479623/
https://www.ncbi.nlm.nih.gov/pubmed/37675011
http://dx.doi.org/10.3389/fneph.2022.847847

Ejemplares similares